Nuvalent . Quarterly Balance Sheets Chart
Quarterly
|
Annual
Nuvalent . Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||
| current assets | |||||||||||||||||
| cash and cash equivalents | 127,470,000 | 120,835,000 | 145,691,000 | 369,244,000 | 77,700,000 | 98,515,000 | 335,387,000 | 88,434,000 | 70,872,000 | 90,115,000 | 241,806,000 | 76,313,000 | 75,915,000 | 67,273,000 | 68,526,000 | 245,886,000 | |
| marketable securities | 878,128,000 | 952,390,000 | 972,611,000 | 799,065,000 | 580,294,000 | 593,322,000 | 384,518,000 | 324,824,000 | 360,367,000 | 360,347,000 | 230,357,000 | 163,751,000 | 181,049,000 | 205,461,000 | 219,585,000 | 56,543,000 | |
| prepaid expenses and other current assets | 14,012,000 | 13,328,000 | 14,146,000 | 11,366,000 | 8,264,000 | 7,657,000 | 6,583,000 | 6,515,000 | 5,753,000 | 5,831,000 | 5,828,000 | 5,181,000 | 1,858,000 | 1,739,000 | 2,517,000 | 2,710,000 | 362,000 |
| total current assets | 1,019,610,000 | 1,086,553,000 | 1,132,448,000 | 1,179,675,000 | 666,258,000 | 699,494,000 | 726,488,000 | 419,773,000 | 436,992,000 | 456,293,000 | 477,991,000 | 245,245,000 | 258,822,000 | 274,473,000 | 290,628,000 | 305,139,000 | 139,281,000 |
| other assets | 20,933,000 | 19,253,000 | 9,304,000 | 9,183,000 | 8,972,000 | 8,972,000 | 5,896,000 | 5,307,000 | 4,956,000 | 4,696,000 | 4,468,000 | 4,313,000 | 4,199,000 | 2,566,000 | 3,196,000 | 2,834,000 | 2,503,000 |
| total assets | 1,040,543,000 | 1,105,806,000 | 1,141,752,000 | 1,188,858,000 | 675,230,000 | 708,466,000 | 732,384,000 | 425,080,000 | 441,948,000 | 460,989,000 | 482,459,000 | 249,558,000 | 263,021,000 | 277,039,000 | 293,824,000 | 307,973,000 | 143,502,000 |
| liabilities and stockholders’ equity | |||||||||||||||||
| current liabilities | |||||||||||||||||
| accounts payable | 13,342,000 | 26,165,000 | 5,225,000 | 15,934,000 | 7,403,000 | 13,396,000 | 9,274,000 | 9,781,000 | 8,117,000 | 6,433,000 | 7,195,000 | 4,620,000 | 4,028,000 | 4,246,000 | 2,893,000 | 2,532,000 | 3,798,000 |
| accrued expenses and other current liabilities | 61,805,000 | 48,869,000 | |||||||||||||||
| total current liabilities | 75,147,000 | 75,034,000 | 54,020,000 | 51,132,000 | 38,192,000 | 33,427,000 | 31,823,000 | 29,103,000 | 20,795,000 | 17,021,000 | 19,481,000 | 12,975,000 | 10,036,000 | 8,124,000 | 8,787,000 | 6,842,000 | 5,829,000 |
| related party revenue share liability | 25,410,000 | 19,370,000 | 17,940,000 | 16,600,000 | |||||||||||||
| other liabilities | 244,000 | 345,000 | |||||||||||||||
| total liabilities | 100,801,000 | 94,749,000 | 71,960,000 | 67,732,000 | 38,192,000 | 33,427,000 | 31,823,000 | 29,103,000 | 20,795,000 | 17,021,000 | 19,481,000 | 12,975,000 | 10,036,000 | 8,124,000 | 8,787,000 | 6,842,000 | 5,829,000 |
| commitments and contingencies | |||||||||||||||||
| stockholders’ equity | |||||||||||||||||
| preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding | |||||||||||||||||
| class a common stock | 7,000 | 7,000 | 7,000 | 7,000 | 6,000 | 6,000 | 6,000 | 5,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | |
| class b convertible common stock, 0.0001 par value; 10,000,000 shares authorized; 5,435,254 shares issued and outstanding at june 30, 2025 and december 31, 2024 | 1,000 | ||||||||||||||||
| additional paid-in capital | 1,669,658,000 | 1,641,829,000 | 1,616,895,000 | 1,592,034,000 | 1,026,546,000 | 1,007,128,000 | 986,819,000 | 645,285,000 | 637,043,000 | 629,533,000 | 623,543,000 | 371,398,000 | 368,350,000 | 365,701,000 | 363,483,000 | 362,083,000 | 1,052,000 |
| accumulated other comprehensive income | 1,363,000 | 854,000 | -59,000 | 1,373,000 | -1,571,000 | -1,318,000 | 31,000 | ||||||||||
| accumulated deficit | -731,287,000 | -631,634,000 | -547,052,000 | -472,289,000 | -387,944,000 | -330,778,000 | -286,296,000 | -248,004,000 | -214,359,000 | -185,269,000 | -160,077,000 | -133,954,000 | -114,238,000 | -95,772,000 | -78,223,000 | -60,934,000 | -48,508,000 |
| total stockholders’ equity | 939,742,000 | 1,011,057,000 | 1,069,792,000 | 1,121,126,000 | 637,038,000 | 675,039,000 | 700,561,000 | 395,977,000 | 421,153,000 | 443,968,000 | 462,978,000 | 252,985,000 | 268,915,000 | 285,037,000 | 301,131,000 | ||
| total liabilities and stockholders’ equity | 1,040,543,000 | 1,105,806,000 | 1,141,752,000 | 1,188,858,000 | 675,230,000 | 708,466,000 | 732,384,000 | 425,080,000 | 441,948,000 | 460,989,000 | 482,459,000 | 263,021,000 | 277,039,000 | ||||
| class b convertible common stock, 0.0001 par value; 10,000,000 shares authorized; 5,435,254 shares issued and outstanding at march 31, 2025 and december 31, 2024 | 1,000 | ||||||||||||||||
| accrued expenses | 48,795,000 | 35,198,000 | 30,789,000 | 20,031,000 | 22,549,000 | 19,322,000 | 12,678,000 | 10,588,000 | 12,286,000 | 8,355,000 | 6,008,000 | 3,878,000 | 5,894,000 | 4,310,000 | 2,031,000 | ||
| class b convertible common stock, 0.0001 par value; 10,000,000 shares authorized; 5,435,254 shares issued and outstanding at december 31, 2024 and 2023 | 1,000 | ||||||||||||||||
| class b common stock | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||
| current assets: | |||||||||||||||||
| current liabilities: | |||||||||||||||||
| stockholders’ equity: | |||||||||||||||||
| accumulated other comprehensive loss | -1,310,000 | -1,537,000 | -302,000 | -494,000 | -866,000 | -1,132,000 | -1,019,000 | -228,000 | -23,000 | ||||||||
| liabilities and stockholders' equity | |||||||||||||||||
| stockholders' equity: | |||||||||||||||||
| total stockholders' equity | 236,583,000 | ||||||||||||||||
| total liabilities and stockholders' equity | 249,558,000 | ||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ equity | |||||||||||||||||
| preferred stock tranche rights | |||||||||||||||||
| notes payable and accrued interest to stockholder | |||||||||||||||||
| convertible preferred stock (series a and b), 0.0001 par value; no shares and 112,431,508 shares authorized at december 31, 2021 and 2020, respectively; no shares and 89,945,206 shares issued and outstanding at december 31, 2021 and 2020, respectively; | |||||||||||||||||
| preferred stock, 0.0001 par value; 10,000,000 shares and no shares authorized at december 31, 2021 and 2020, respectively; no shares issued or outstanding | |||||||||||||||||
| promissory note from stockholder | -284,000 | ||||||||||||||||
| total liabilities, convertible preferred stock and stockholders’ equity | 293,824,000 | 307,973,000 | |||||||||||||||
| convertible preferred stock (series a and b), 0.0001 par value; no shares and 112,431,508 shares authorized at september 30, 2021 and december 31, 2020, respectively; no shares and 89,945,206 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively; | |||||||||||||||||
| preferred stock, 0.0001 par value; 10,000,000 shares and no shares authorized at september 30, 2021 and december 31, 2020, respectively; no shares issued or outstanding | |||||||||||||||||
| cash | 138,919,000 | ||||||||||||||||
| deferred offering costs | 1,718,000 | ||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ deficit | |||||||||||||||||
| convertible preferred stock (series a and b), 0.0001 par value; 182,680,791 shares and 112,431,508 shares authorized at june 30, 2021 and december 31, 2020, respectively; 182,680,791 shares and 89,945,206 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively; liquidation preference of 187,235 at june 30, 2021 | 185,413,000 | ||||||||||||||||
| stockholders’ deficit: | |||||||||||||||||
| common stock | |||||||||||||||||
| total stockholders’ deficit | -47,740,000 | ||||||||||||||||
| total liabilities, convertible preferred stock and stockholders’ deficit | 143,502,000 |
We provide you with 20 years of balance sheets for Nuvalent . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Nuvalent .. Explore the full financial landscape of Nuvalent . stock with our expertly curated balance sheets.
The information provided in this report about Nuvalent . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.